ClinVar Miner

Submissions for variant NM_001037.5(SCN1B):c.461T>C (p.Met154Thr)

dbSNP: rs1432198305
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000646748 SCV000768533 uncertain significance Brugada syndrome 5 2024-06-28 criteria provided, single submitter clinical testing The SCN1B gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_001037.5, and corresponds to NM_199037.3:c.*5031T>C in the primary transcript. This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 154 of the SCN1B protein (p.Met154Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SCN1B-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001584490 SCV001820757 uncertain significance not provided 2019-12-10 criteria provided, single submitter clinical testing Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Ambry Genetics RCV002331208 SCV002633399 uncertain significance Cardiovascular phenotype 2022-06-27 criteria provided, single submitter clinical testing The c.461T>C (p.M154T) alteration is located in exon 4 (coding exon 4) of the SCN1B gene. This alteration results from a T to C substitution at nucleotide position 461, causing the methionine (M) at amino acid position 154 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV004735710 SCV005366109 uncertain significance SCN1B-related disorder 2024-06-13 no assertion criteria provided clinical testing The SCN1B c.461T>C variant is predicted to result in the amino acid substitution p.Met154Thr. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.